BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 9110069)

  • 1. CD8+ T-cell-mediated suppression of HIV replication in the first year of life: association with lower viral load and favorable early survival.
    Pollack H; Zhan MX; Safrit JT; Chen SH; Rochford G; Tao PZ; Koup R; Krasinski K; Borkowsky W
    AIDS; 1997 Jan; 11(1):F9-13. PubMed ID: 9110069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD8+ T cells from HIV type 1-seronegative individuals suppress virus replication in acutely infected cells.
    Røsok B; Voltersvik P; Larsson BM; Albert J; Brinchmann JE; Asjö B
    AIDS Res Hum Retroviruses; 1997 Jan; 13(1):79-85. PubMed ID: 8989430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-Specific CD8+ T Cell-Mediated Viral Suppression Correlates With the Expression of CD57.
    Jensen SS; Tingstedt JL; Larsen TK; Brandt L; Gerstoft J; Kronborg G; Pedersen C; Fomsgaard A; Karlsson I
    J Acquir Immune Defic Syndr; 2016 Jan; 71(1):8-16. PubMed ID: 26761268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies.
    Chun TW; Justement JS; Moir S; Hallahan CW; Ehler LA; Liu S; McLaughlin M; Dybul M; Mican JM; Fauci AS
    Proc Natl Acad Sci U S A; 2001 Jan; 98(1):253-8. PubMed ID: 11136258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Notwithstanding Circumstantial Alibis, Cytotoxic T Cells Can Be Major Killers of HIV-1-Infected Cells.
    Gadhamsetty S; Coorens T; de Boer RJ
    J Virol; 2016 Aug; 90(16):7066-7083. PubMed ID: 27226367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8(+)-Cell antiviral factor activity is not restricted to human immunodeficiency virus (HIV)-specific T cells and can block HIV replication after initiation of reverse transcription.
    Le Borgne S; Février M; Callebaut C; Lee SP; Rivière Y
    J Virol; 2000 May; 74(10):4456-64. PubMed ID: 10775581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus type 1 replication, immune activation, and circulating cytotoxic T cells against uninfected CD4+ T cells.
    Kottilil S; Gamberg J; Bowmer I; Trahey J; Howley C; Gallant M; Grant M
    J Clin Immunol; 2000 May; 20(3):175-86. PubMed ID: 10941825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual function of a human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte clone: inhibition of HIV replication by noncytolytic mechanisms and lysis of HIV-infected CD4+ cells.
    Buseyne F; Février M; Garcia S; Gougeon ML; Rivière Y
    Virology; 1996 Nov; 225(1):248-53. PubMed ID: 8918556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-2 production by polyfunctional HIV-1-specific CD8 T cells is associated with enhanced viral suppression.
    Akinsiku OT; Bansal A; Sabbaj S; Heath SL; Goepfert PA
    J Acquir Immune Defic Syndr; 2011 Oct; 58(2):132-40. PubMed ID: 21637109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors related to loss of HIV-specific cytotoxic T lymphocyte activity.
    Gamberg J; Barrett L; Bowmer MI; Howley C; Grant M
    AIDS; 2004 Mar; 18(4):597-604. PubMed ID: 15090764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of the T-cell receptor CD4 and CD8 V beta repertoire in HIV-1 vertically infected infants early treated with HAART.
    Romiti ML; Cancrini C; Castelli-Gattinara G; Di Cesare S; Ciaffi P; Bernardi S; De Gasperi MR; Halapi E; Rossi P
    AIDS; 2001 Nov; 15(16):2075-84. PubMed ID: 11684926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8+ T cell-mediated suppression of human immunodeficiency virus replication in older children with acquired immunodeficiency syndrome.
    Salimi B; Yogev R; Kabat W; O'Gorman MR; Katz BZ
    Pediatr Infect Dis J; 2000 Feb; 19(2):109-13. PubMed ID: 10693995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infrequent detection of HIV-1-specific, but not cytomegalovirus-specific, CD8(+) T cell responses in young HIV-1-infected infants.
    Scott ZA; Chadwick EG; Gibson LL; Catalina MD; McManus MM; Yogev R; Palumbo P; Sullivan JL; Britto P; Gay H; Luzuriaga K;
    J Immunol; 2001 Dec; 167(12):7134-40. PubMed ID: 11739536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection.
    Musey L; Hughes J; Schacker T; Shea T; Corey L; McElrath MJ
    N Engl J Med; 1997 Oct; 337(18):1267-74. PubMed ID: 9345075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficiency of HIV-Gag-specific T cells in early childhood correlates with poor viral containment.
    Huang S; Dunkley-Thompson J; Tang Y; Macklin EA; Steel-Duncan J; Singh-Minott I; Ryland EG; Smikle M; Walker BD; Christie CD; Feeney ME
    J Immunol; 2008 Dec; 181(11):8103-11. PubMed ID: 19018003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles.
    Koofhethile CK; Ndhlovu ZM; Thobakgale-Tshabalala C; Prado JG; Ismail N; Mncube Z; Mkhize L; van der Stok M; Yende N; Walker BD; Goulder PJR; Ndung'u T
    J Virol; 2016 Aug; 90(15):6818-6831. PubMed ID: 27194762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perspectives on inducing efficient immune control of HIV-1 replication--a new goal for HIV therapeutics?
    Bucy RP; Kilby JM
    AIDS; 2001 Feb; 15 Suppl 2():S36-42. PubMed ID: 11424975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcome of HIV viraemic controllers and noncontrollers with normal CD4 counts is exclusively determined by antigen-specific CD8+ T-cell-mediated HIV suppression.
    Tansiri Y; Rowland-Jones SL; Ananworanich J; Hansasuta P
    PLoS One; 2015; 10(3):e0118871. PubMed ID: 25764310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent low viral load on antiretroviral therapy is associated with T cell-mediated control of HIV replication.
    Alatrakchi N; Duvivier C; Costagliola D; Samri A; Marcelin AG; Kamkamidze G; Astriti M; Agher R; Calvez V; Autran B; Katlama C
    AIDS; 2005 Jan; 19(1):25-33. PubMed ID: 15627030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated Expression of miR-19b Enhances CD8
    Yin LB; Song CB; Zheng JF; Fu YJ; Qian S; Jiang YJ; Xu JJ; Ding HB; Shang H; Zhang ZN
    Front Immunol; 2018; 9():3140. PubMed ID: 30687333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.